Why is Panacea Biotec falling/rising?

As of 11-Aug, Panacea Biotec Ltd is experiencing a decline in its stock price, currently at Rs 392.00, which represents a decrease of Rs 20.9 or 5.06%. The stock has underperformed its sector by 5.97% today and has shown a trend reversal after two consecutive days of gains. It reached an intraday low of Rs 381.05, reflecting a significant drop of 7.71%. The stock is trading below its moving averages across various time frames, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 40.47% compared to the five-day average. Despite a remarkable one-year return of 191.34%, the company is facing severe operational challenges, including significant operating losses and a weak ability to service its debt, which has contributed to the stock's recent downturn.
In the broader market context, Panacea Biotec's short-term performance has been notably worse than the benchmark, with a one-week return of -4.84% compared to the Sensex's -0.51%. While the stock has outperformed the market over the past year, the current volatility and negative financial indicators suggest a lack of confidence among investors. The company's poor long-term growth prospects, evidenced by a staggering annual decline in operating profit and negative EBITDA, further exacerbate the situation. Additionally, the absence of domestic mutual fund investment may indicate a lack of confidence in the company's future performance, contributing to the stock's decline.